Ovid Therapeutics Inc. (NASDAQ:OVID) announced that the European Commission (EC) has granted orphan drug designation (ODD) to OV101 (gaboxadol) for the treatment of Angelman syndrome …
Endo International plc (NASDAQ:ENDP)said that it was taking out a $300 million loan. Endo, a generic drugmaker, has been sued nearly 2,000 times in connection …
The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider …
Western Digital Corporation (NASDAQ:WDC) was downgraded to Sell from Hold with a $40 price target at Benchmark. The insider ownership percentage is the key indicator, …
Macerich Company (NYSE:MAC) President Edward C. Coppola purchased 3,500 shares of the company’s stock in a transaction that occurred on Friday, June 28th. The shares …
The Greenbrier Companies, Inc. (NYSE:GBX) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $0.96 per share. This compares …
The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider …
The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider …
Vuzix Corporation (NASDAQ:VUZI) rose 16.5% in pre-market trading. Vuzix announced a $20 million registered direct offering. The insider ownership percentage is the key indicator, can …
The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider …
Raymond James analyst Aaron Kessler initiates coverage on Revolve Group, Inc. (NYSE:RVLV) with an Outperform rating and a price target of $40.00. The insider ownership …
Eros International Plc (NYSE:EROS)reports that outstanding interest payments of the Company’s Indian operating subsidiary (EIML) that caused a recent ratings downgrade by CARE have been …
Cemtrex, Inc. (NASDAQ:CETX) shares tumbled 19.2% after the company priced its registered offering of 224,215 shares at $2.23 per share. The insider ownership percentage is …
Xenetic Biosciences, Inc. (NASDAQ:XBIO) has filed a preliminary prospectus for a public offering of 1,555,555 common shares and warrants to purchase same number of common …
Iovance Biotherapeutics stock jumped Climbs2.36% in premarket trade Tuesday after the company gave some positive updates on the regulatory pathway of a potential treatment for …